Literature DB >> 2891717

Developmentally regulated primary glucocorticoid hormone induction of chick retinal glutamine synthetase mRNA.

G Patejunas1, A P Young.   

Abstract

We have characterized the glucocorticoid hormone induction of glutamine synthetase mRNA in embryonic chick retinal organ cultures by quantitative dot hybridization using a cDNA clone derived from chick retinal RNA. Hydrocortisone (Kapp = 3-4 nM) and dexamethasone (Kapp = 1-2 nM) produce an approximate 30-fold increase in glutamine synthetase mRNA after incubation of organ cultures derived from embryonic day 12 retinae with either hormone for 3 hr. Progesterone is a poor inducer. The glucocorticoid-mediated rise is rapid (t1/2 = 2-3 hr) and occurs in the presence of either of the protein synthesis inhibitors cycloheximide or puromycin, indicating that the induction is a primary or direct response to the hormone. However, the magnitude of the hormonal response observed in culture increases markedly during retinal development. These observations, coupled with the previously reported absence of a hormonal induction in embryonic liver, raise the possibility of a synergistic mechanism, involving tissue-specific regulatory molecules in addition to the glucocorticoid hormone receptor, to explain the retinal-specific primary glucocorticoid hormone induction of glutamine synthetase mRNA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2891717     DOI: 10.1002/jcb.240350304

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  2 in total

1.  Glutamine synthetase protects against neuronal degeneration in injured retinal tissue.

Authors:  R Gorovits; N Avidan; N Avisar; I Shaked; L Vardimon
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

2.  Developmental control of glucocorticoid receptor transcriptional activity in embryonic retina.

Authors:  I Ben-Dror; N Havazelet; L Vardimon
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-01       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.